1. High‐dose chemotherapy for relapsed germ cell tumours: outcomes in low‐volume specialized centres. (31st March 2022) Authors: Connolly, Elizabeth A.; Weickhardt, Andrew; Grimison, Peter; Asher, Rebecca; Heller, Gillian Z.; Lewin, Jeremy; Liow, Elizabeth; Toner, Guy; Tung, Iris L.Y.; Tran, Ben; Hill, Sean; Walpole, Euan; McKenzie, Jane; Kuchel, Anna; Goh, Jeffrey; Forgeson, Garry; Tan, Alvin; Joshi, Abhishek; Wickham, Al... Journal: BJU international Issue: Volume 130(2022)Supplement 1 Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immune checkpoint inhibitors in kidney transplant recipients: a multicentre, single-arm, phase 1 study. Issue 8 (August 2022) Authors: Carroll, Robert P; Boyer, Michael; Gebski, Val; Hockley, Bronwyn; Johnston, Julie K; Kireta, Svjetlana; Tan, Hsiang; Taylor, Anne; Wyburn, Kate; Zalcberg, John R Journal: Lancet oncology Issue: Volume 23:Issue 8(2022) Page Start: 1078 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial. Issue 4 (April 2023) Authors: Sweeney, Christopher J; Martin, Andrew J; Stockler, Martin R; Begbie, Stephen; Cheung, Leanna; Chi, Kim N; Chowdhury, Simon; Frydenberg, Mark; Horvath, Lisa G; Joshua, Anthony M; Lawrence, Nicola J; Marx, Gavin; McCaffrey, John; McDermott, Ray; McJannett, Margaret; North, Scott A; Parnis, Francis... Journal: Lancet oncology Issue: Volume 24:Issue 4(2023) Page Start: 323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗